Clayface's best shot at the box office is audiences not realising it's a DC film
A $40 million Batman villain film whose best customers may be people who have never heard of Batman's villains. Warner Bros. can't exactly say that out loud.
Clayface opens in UK and US cinemas on 23 October, rated R, on a $40 million budget, with a body horror pitch James Gunn has called "a complete horror film". Early tracking puts its US opening weekend at $23–33 million. On 14 October a thread on r/boxoffice asked the obvious question: will the gore scare off the comic book crowd, or pull in the horror crowd? By the next morning it had 137 comments, and the sharpest ones answered a different question.
"Good word of mouth could help as long as its not too much associated with DC"
— r/boxoffice commenter, 51 upvotes
Another went further: "most non-comic book fans do not know that clayface is a comic book character, and will just assume it's a regular horror film." Fair enough. To most people outside the fandom, Clayface sounds like a pottery class gone wrong, not a Batman villain.
Our view: this is the first DC film that will sell more tickets the fewer people realise it is DC.
Horror is outselling capes this year
The numbers from 2026 are not kind to the logo. Compare the year's biggest horror hit with the DCU's summer release:
- Obsession: Curry Barker's Blumhouse and Focus Features chiller, sold mostly on word of mouth and TikTok buzz with little advertising, made $224.7 million worldwide. It is the top-grossing horror film of the year and Focus's biggest film ever.
- Supergirl: the second DCU film, with the full weight of the brand behind it, stopped at $126 million worldwide in June.
- Terrifier 3 (2024): an unrated slasher about a mime clown, made around $87 million.
The r/boxoffice crowd said as much: "Obsession REALLY benefitted from good word of mouth." Nobody went to see it because of a shared universe. Superman made $619 million last year, and the DC name did its job there. One film later, it was no longer a guarantee of anything.
A horror fan who walked out of Obsession raving owes Gotham nothing. If Clayface reaches that viewer as a new Mike Flanagan-scripted horror film about an actor whose face melts, it has a chance. If it reaches them as "DCU Chapter One, part three", it is homework.
Body horror is the harder sell
To be fair, the sceptics in the thread have a point. Body horror is a niche inside a niche. The Substance won an Oscar for its make-up, had Demi Moore on every talk show and still made $77.3 million worldwide. That was a hit for what it was, and Clayface needs to clear its budget by a fair margin.
The closest comparison is not encouraging either. The New Mutants was pitched as an X-Men horror film, sat on a shelf through the Disney-Fox merger and finally came out in the 2020 pandemic, making under $50 million worldwide on a reported $67 million budget.
The DC logo sold Superman. For Clayface, it might be the scariest thing on the poster.
Gunn, at least, knows the territory. He wrote Zack Snyder's Dawn of the Dead in 2004 and directed the gloriously nasty Slither in 2006, long before anyone handed him a cape.
Reviews arrive on 21 October, two days before release. If Clayface opens well on horror word of mouth, Gunn has a recipe for cheap DCU films that don't need Superman to sell. If it doesn't, the DCU has two disappointments in a row and a $40 million lesson. For once, the less DC puts on the poster, the more DC might sell.